Article Details
Retrieved on: 2021-10-08 13:17:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pyxis has had a great year, having licensed a pair of antibody-drug conjugates (ADCs) from Pfizer and raised a mega $152 million B round to develop them.
Article found on: www.fiercebiotech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here